F.D.A. Experts Find No Misconduct in Avandia Tests

As an F.D.A. advisory panel revisits the debate around the diabetes drug Avandia, a report by staff experts found no fraud in its clinical trial.    

Source: NYT Health - June 3, 2013 Category: Consumer Health News Authors: By KATIE THOMAS Tags: Clinical Trials Drugs (Pharmaceuticals) Avandia (Drug) Food and Drug Administration GlaxoSmithKline PLC GSK NYSE Source Type: news